In West Germany, Biotechnology Faces Its Day Of Reckoning

The Bundestag is about to hand down a decision whether biotech work can continue FRANKFURT--It's not often that a country grapples publicly with its future in a key area of science and technology. But that's what is happening now in West Germany. Later this month, a plenary session of the Bundestag (the nation's parliament) will begin debating the report of a parliamentary commission, entitled Prospects and Risks of Genetic Engineering, which recommends a total ban on the release of genetical

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

FRANKFURT--It's not often that a country grapples publicly with its future in a key area of science and technology. But that's what is happening now in West Germany. Later this month, a plenary session of the Bundestag (the nation's parliament) will begin debating the report of a parliamentary commission, entitled Prospects and Risks of Genetic Engineering, which recommends a total ban on the release of genetically manipulated microorganisms into the environment. The results of this debate are likely to be formalized in West Germany's first comprehensive law on recombinant DNA activities, expected to be passed by the end of May.

To say that West Germans are anxiously awaiting the law would be an understatement. Scientists, naturally, are worried that the government will make it impossible to continue their experiments. Restrictive regulations have already turned West Germany into one of the most difficult places in the world to do molecular biology. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Dede Williams

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours